Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors

作者: Ashraf Badros , Dianna Weikel , Andrew Salama , Olga Goloubeva , Abraham Schneider

DOI: 10.1200/JCO.2005.04.2465

关键词: SurgeryRetrospective cohort studyThalidomideOsteonecrosis of the jawMedicineDental extractionTransplantationBisphosphonate-associated osteonecrosis of the jawMultiple myelomaRisk factor

摘要: Purpose To describe the clinical, radiologic, and pathologic features risk factors for osteonecrosis of jaw (ONJ) in multiple myeloma (MM) patients. Patients Methods A retrospective review 90 MM patients who had dental assessments, including 22 with ONJ. There were 62 men; median age was 61 years ONJ 58 among rest. Prior therapy included thalidomide (n = 67) stem-cell transplantation 72). Bisphosphonate zoledronate 34) or pamidronate 17) followed by 33). Twenty-seven recent extraction, 12 group. Median time from diagnosis to 8.4 whole Results usually presented pain. occurred posterior cuspids 20) mostly mandible. Debridement sequestrectomy primary closure performed 14 patients; these, four major infections recu...

参考文章(45)
Sun Jin Choi, Jose C. Cruz, Fiona Craig, Hoyeon Chung, Rowena D. Devlin, G. David Roodman, Melissa Alsina, Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma Blood. ,vol. 96, pp. 671- 675 ,(2000) , 10.1182/BLOOD.V96.2.671
Thiel Hj, [Osteoradionecrosis. I. Etiology, pathogenesis, clinical aspects and risk factors]. Radiobiologia, radiotherapia. ,vol. 30, pp. 397- 413 ,(1989)
Martin Pecherstorfer, Markus J. Seibel, Henning W. Woitge, Eva Horn, Judith Schuster, Jane Neuda, Peter Sagaster, Horst Köhn, Peter Bayer, Daniel Thiébaud, Heinz Ludwig, Bone Resorption in Multiple Myeloma and in Monoclonal Gammopathy of Undetermined Significance: Quantification by Urinary Pyridinium Cross-Links of Collagen Blood. ,vol. 90, pp. 3743- 3750 ,(1997) , 10.1182/BLOOD.V90.9.3743
Osteonecrosis of the jaw and bisphosphonates. The New England Journal of Medicine. ,vol. 353, pp. 99- 102 ,(2005) , 10.1056/NEJM200507073530120
Patrick M Purcell, Ian W Boyd, Bisphosphonates and osteonecrosis of the jaw. The Medical Journal of Australia. ,vol. 182, pp. 417- 418 ,(2005) , 10.5694/J.1326-5377.2005.TB06762.X
J R Berenson, A Lichtenstein, L Porter, M A Dimopoulos, R Bordoni, S George, A Lipton, A Keller, O Ballester, M Kovacs, H Blacklock, R Bell, J F Simeone, D J Reitsma, M Heffernan, J Seaman, R D Knight, Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. Journal of Clinical Oncology. ,vol. 16, pp. 593- 602 ,(1998) , 10.1200/JCO.1998.16.2.593
Michael Rogers, New insights into the molecular mechanisms of action of bisphosphonates. Current Pharmaceutical Design. ,vol. 9, pp. 2643- 2658 ,(2003) , 10.2174/1381612033453640
Resa Mostofi, Hugh Marchmont-Robinson, Steven Freije, Spontaneous tooth exfoliation and osteonecrosis following a herpes zoster infection of the fifth cranial nerve Journal of Oral and Maxillofacial Surgery. ,vol. 45, pp. 264- 266 ,(1987) , 10.1016/0278-2391(87)90126-1
Esa Jantunen, Bisphosphonate therapy in multiple myeloma: past, present, future. European Journal of Haematology. ,vol. 69, pp. 257- 264 ,(2002) , 10.1034/J.1600-0609.2002.02796.X
Salvatore L Ruggiero, Bhoomi Mehrotra, Tracey J Rosenberg, Stephen L Engroff, Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases Journal of Oral and Maxillofacial Surgery. ,vol. 62, pp. 527- 534 ,(2004) , 10.1016/J.JOMS.2004.02.004